Inclusive of all taxes
Gliclazide Modified-release Tablets 60 mg are a premium pharmaceutical formulation designed specifically for the effective management of diabetes mellitus. Crafted under stringent export-quality standards and WHO-GMP compliant manufacturing facilities, these tablets ensure reliable and consistent therapeutic outcomes for diabetic patients. The modified-release formulation guarantees a controlled release of active ingredients, optimizing glycemic control over an extended period, thereby enhancing patient compliance and reducing dosing frequency. Packaged in export-grade blister or strip packs, this product is tailored for seamless international distribution and use in hospital and retail pharmacy settings. Manufactured by IndiGlobal Exports with adherence to IP/USP pharmacopoeial standards, these tablets stand out for their precision dosage form, safety, and high efficacy profile, making them an ideal choice for regulated and semi-regulated markets worldwide.
Key Features
| Features | Description |
|---|---|
| Dosage Strength | 60 mg per tablet |
| Formulation Type | Modified-release tablets for sustained drug delivery |
| Therapeutic Use | Management of diabetes mellitus (Type 2 diabetes) |
| Manufacturing Standards | WHO-GMP compliant manufacturing facilities |
| Packaging | Export-quality blister or strip packs suitable for bulk and institutional supply |
| Quality Compliance | Adheres to IP/USP pharmacopoeial quality benchmarks |
| Manufacturer | IndiGlobal Exports |
| Shelf Life | As per international regulatory standards |
| Intended Use | Hospitals, retail pharmacies, and regulated export markets |
| Attributes | Description |
|---|---|
| Active Ingredient | Gliclazide |
| Strength per Tablet | 60 mg |
| Dosage Form | Modified-release Tablet |
| Therapeutic Class | Antidiabetic agent |
| Packaging Type | Blister or strip packs |
| Compliance Standards | WHO-GMP, IP/USP quality standards |
| Shelf Life | As per regulatory guidelines, typically 24 months |
| Intended Markets | International export including regulated and semi-regulated pharmaceutical markets |
| Manufacturer | IndiGlobal Exports |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
The modified-release formulation ensures a controlled and sustained release of Gliclazide over time, which helps in maintaining stable blood glucose levels and reduces the frequency of dosing, thereby enhancing patient adherence.
Yes, these tablets are manufactured under WHO-GMP compliance and meet IP/USP pharmacopoeial standards, making them suitable for export to both regulated and semi-regulated international pharmaceutical markets.
The product is typically available in export-quality blister or strip packs designed for bulk supply to hospitals, pharmacies, and institutional clients.
IndiGlobal Exports is the reputable manufacturer producing these tablets in GMP-compliant facilities with stringent quality control.
The shelf life is as per international regulatory standards, commonly around 24 months, ensuring product stability and efficacy throughout its usage period.
Brand: indiglobal exports
Country Of Origin: India
Gliclazide Modified-release Tablets 60 mg is a pharmaceutical product indicated for diabetes treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations.
Features:Gliclazide Modified-release Tablets 60 mg is developed for the effective management of diabetes conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.
This formulation supports the clinical treatment and ongoing care of patients with diabetes indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.
Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.
The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.
Inclusive of all taxes
You Save: 0
Panchkula , India
Service Provider , Professional Services, Exporter, Wholesaler
GST- 06eogps3248l1zf
